1. Home
  2. BCAB vs BANL Comparison

BCAB vs BANL Comparison

Compare BCAB & BANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • BANL
  • Stock Information
  • Founded
  • BCAB 2007
  • BANL 2015
  • Country
  • BCAB United States
  • BANL Malaysia
  • Employees
  • BCAB N/A
  • BANL N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • BANL Oil Refining/Marketing
  • Sector
  • BCAB Health Care
  • BANL Energy
  • Exchange
  • BCAB Nasdaq
  • BANL Nasdaq
  • Market Cap
  • BCAB 21.6M
  • BANL 25.3M
  • IPO Year
  • BCAB 2020
  • BANL 2023
  • Fundamental
  • Price
  • BCAB $0.45
  • BANL $0.65
  • Analyst Decision
  • BCAB Hold
  • BANL
  • Analyst Count
  • BCAB 3
  • BANL 0
  • Target Price
  • BCAB $1.00
  • BANL N/A
  • AVG Volume (30 Days)
  • BCAB 561.4K
  • BANL 79.5K
  • Earning Date
  • BCAB 08-07-2025
  • BANL 09-11-2025
  • Dividend Yield
  • BCAB N/A
  • BANL N/A
  • EPS Growth
  • BCAB N/A
  • BANL N/A
  • EPS
  • BCAB N/A
  • BANL N/A
  • Revenue
  • BCAB $11,000,000.00
  • BANL $592,517,545.00
  • Revenue This Year
  • BCAB N/A
  • BANL N/A
  • Revenue Next Year
  • BCAB N/A
  • BANL N/A
  • P/E Ratio
  • BCAB N/A
  • BANL N/A
  • Revenue Growth
  • BCAB N/A
  • BANL 35.93
  • 52 Week Low
  • BCAB $0.24
  • BANL $0.55
  • 52 Week High
  • BCAB $2.53
  • BANL $1.35
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 65.33
  • BANL 38.31
  • Support Level
  • BCAB $0.35
  • BANL $0.65
  • Resistance Level
  • BCAB $0.38
  • BANL $0.70
  • Average True Range (ATR)
  • BCAB 0.03
  • BANL 0.04
  • MACD
  • BCAB 0.01
  • BANL 0.00
  • Stochastic Oscillator
  • BCAB 90.66
  • BANL 18.94

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

Share on Social Networks: